Skip to main content
Caplight Logo









Accipiter Biosciences

Accipiter Biosciences

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://accipiterbio.com/

Last Round

Seed

Jul 28, 2026

Total Funding Raised

$26.85M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Accipiter Biosciences is a biotechnology company that develops de novo multifunctional biologics to treat complex diseases using its computational platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

de novo protein designcomputational drug discoverybiologic therapeuticsprotein engineeringai drug discoveryin silico drug designmultifunctional biologicsoncology therapeuticsimmunology drug developmentbiotech r&ddrug discovery platformprecision medicineprotein therapeuticspharma partnershipai biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Accipiter Biosciences Comparables

Compare Accipiter Biosciences with similar companies based on industry and business-model similarity.

Accipiter Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Archon Biosciences
87%
AI Proteins
85%
Ability Biotherapeutics
83%

Accipiter Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 28, 2026
SeedNov 6, 2025
SeedNov 6, 2025
Pre SeedMay 2, 2023
SeedMar 27, 2023

Key People

Founding team and executive leadership

Javier Castellanos

Chief Technology Officer and Co-founder

Founding Team

Matthew Bick

CEO and co-founder

Founding Team

Accipiter Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    $10.5M raised in Seed Round.

  • Jun 23, 2026

    Monthly visitors increased 682% MoM, from 174 to 1.4K.

Accipiter Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Accipiter Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Accipiter Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range24
Year Founded2023
Last FundingJul 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?